Search

Heron Therapeutics Inc

Suletud

SektorTervishoid

0.36 16.13

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.31

Max

0.36

Põhinäitajad

By Trading Economics

Sissetulek

2.6M

-5.5M

Müük

3M

38M

Aktsiakasum

-0.03

Kasumimarginaal

-14.573

Töötajad

128

EBITDA

2.1M

-5.5M

Dividendid

By Acuity

Järgmine tulemuste avaldamine

3. nov 2026

Turustatistika

By TradingEconomics

Turukapital

-41M

55M

Eelmine avamishind

-15.77

Eelmine sulgemishind

0.36

Uudiste sentiment

By Acuity

30%

70%

47 / 339 Pingereas Healthcare

Heron Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

1. okt 2026, 23:40 UTC

News

Turning Point Brands Inc. shares rose in after-market trading following CEO Graham Purdy's immediate resignation and the appointment of David E. Glazek as his successor.

1. okt 2026, 23:30 UTC

News

Vertex Pharmaceuticals Inc is trading modestly higher in after-market hours, recovering from earlier declines but remains below its 20-day moving average.

1. okt 2026, 23:25 UTC

News

Broadridge Financial Solutions Inc. nominates Srinivas D. Tallapragada to its Board of Directors, with shares modestly higher in after-market trading.

1. okt 2026, 23:20 UTC

News
Social Media

Lyft Inc has agreed to a $272.5 million settlement over driver misclassification claims, with shares modestly lower in after-market trading.

1. okt 2026, 23:20 UTC

Social Media
News

Mattel Inc shares rise in after-market trading amid reported takeover interest from Authentic Brands Group, with a potential bid valuing the company at $6 billion.

1. okt 2026, 23:16 UTC

News

Skyworks Solutions Inc is set to acquire Qorvo, contributing to a modest rise in after-market trading as the deal nears finalization.

1. okt 2026, 23:15 UTC

News

Wells Fargo initiated coverage of Blue Owl Capital Inc with an Equal Weight rating and $10.00 price target; shares are higher in after-market trading.

1. okt 2026, 23:10 UTC

News

Apollo Global Management's stock rose in after-market trading following Wells Fargo's Equal Weight rating and $127.00 price target initiation by analyst Daniel Welden.

1. okt 2026, 23:06 UTC

News

Twilio Inc will replace Warner Bros. Discovery in the S&P 500 on October 6, 2026, contributing to the stock's positive after-market hours performance.

1. okt 2026, 23:06 UTC

News
Correlated Moves

NextDecade shares are higher in after-market trading following Giovanni Oddo's board resignation, with gains likely influenced by Venture Global's LNG sales agreement.

1. okt 2026, 23:06 UTC

News

Chevron's shipments from Venezuela remained stable at 283k barrels per day in September, contributing to a slight increase in shares during after-market trading.

1. okt 2026, 23:06 UTC

News
Correlated Moves

Caterpillar Inc. is little changed in after-market trading after announcing a $1 billion investment to expand manufacturing in Sanford, North Carolina.

1. okt 2026, 23:05 UTC

News

Boston Scientific Corp's shares are trading modestly lower in after-market hours, marking the fifth consecutive session of declines, following Elutia's $8 million escrow release.

1. okt 2026, 23:05 UTC

News

Wells Fargo analyst Daniel Welden initiated coverage on Blackstone Inc with an Equal Weight rating and a price target of $122.00, as shares trade higher in after-market hours.

1. okt 2026, 23:05 UTC

News

Synopsys Inc is trading slightly higher in after-market hours, following discussions of new partnerships with OpenAI and Amazon during its investor day.

1. okt 2026, 23:01 UTC

News

UBS analyst Sasha Sanwal has initiated coverage of Helmerich & Payne with a Buy rating and a price target of $49.00, as shares rise in after-market trading.

1. okt 2026, 23:01 UTC

News

DICK'S Sporting Goods Inc is declining in after-market trading amid a class action lawsuit and disappointing Q2 results, with EPS of $3.53 missing estimates of $3.76.

1. okt 2026, 23:01 UTC

Social Media
News

Synaptics Inc shares rose in after-market hours following an amended merger agreement with onsemi to acquire Synaptics for $123 per share, valuing the deal at $5.7 billion.

1. okt 2026, 23:01 UTC

News
Correlated Moves

ON Semiconductor Corp's revised merger agreement with Synaptics lowers the acquisition price to $123 per share, boosting ON shares significantly in after-market trading.

1. okt 2026, 23:01 UTC

News

NZD/JPY fell sharply as Japan reported a significant outflow of 362 billion yen in foreign investments, positioning the currency pair below its 20-day moving average.

1. okt 2026, 23:01 UTC

News

Karyopharm Therapeutics shares are advancing in after-market trading following the grant of 333 restricted stock units to a new employee.

1. okt 2026, 23:01 UTC

News

Target Hospitality Corp is trading sharply lower in after-market hours amid reports of an 11 million share block trade marketed by Morgan Stanley.

1. okt 2026, 23:01 UTC

News

TransUnion shares are declining in after-market trading amid reports that the FHFA may limit credit data sources for lenders to two bureaus.

1. okt 2026, 23:01 UTC

News

HP Inc. shares are trading modestly lower in after-hours, following the launch of the new OmniBook 5 14 laptop designed to compete with Apple's MacBook Neo.

1. okt 2026, 23:01 UTC

News

Fair Isaac Corp shares fell sharply in after-hours trading following a report on potential changes to credit data sourcing by the Federal Housing Finance Agency.

1. okt 2026, 23:01 UTC

News
Social Media
Event

Nike Inc's stock declined in after-market trading following a revenue miss of $11.21 billion and lowered fiscal 2027 EPS guidance to $1.15-$1.35.

1. okt 2026, 23:01 UTC

Correlated Moves
News

The USD/PLN currency pair is trading higher, supported by hawkish comments from Neel Kashkari and strong U.S. labor market data.

1. okt 2026, 23:01 UTC

News

The USD/DKK currency pair is trading modestly higher, supported by hawkish Federal Reserve comments and lower-than-expected initial jobless claims.

1. okt 2026, 23:01 UTC

News
Correlated Moves

Hawkish Fed comments and strong U.S. labor data have led to a modest increase in the USD/CZK currency pair, supported by a strengthening US dollar.

1. okt 2026, 23:01 UTC

Macro News
Correlated Moves
News

The Japanese yen weakened against major currencies, with USD/JPY trading higher amid rising U.S. Treasury yields and hawkish Fed comments.

Võrdlus sarnastega

Hinnamuutus

Heron Therapeutics Inc Prognoos

Hinnangu Konsensus

By TipRanks

Neutraalne

2 ratings

0

Osta

2

Hoia

0

Müü

Sentiment

By Acuity

47 / 339 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Heron Therapeutics Inc

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.